Hépato-Gastro & Oncologie Digestive

Volume 29, supplement 2, July 2022

ÉDITORIAL

The patient at the centre of our concerns: finally, a reality (p.5-7)
Xavier Roblin

MINI-REVUES

Efficacy of currently available treatments after failure of a first-line anti-TNF (p.9-16)
Pauline Rivière, David Laharie

The IBD patient at the centre of management: The importance of tolerance in the choice of treatments (p.17-22)
Paul McLellan, Laurent Beaugerie, Julien Kirchgesner

How to choose the best route for administering the treatment to the patients with inflammatory bowel disease? (p.23-7)
Anthony Buisson

Noninvasive monitoring: An asset for the patient? (p.29-36)
Stéphane Nancey